OTPP subrecipients increase access to all forms of Medication-Assisted Recovery, particularly in regions of the state inadequately served by existing opioid treatment programs and medication units.
OTPP subrecipients are expected to:
Establish a location for outpatient treatment program services.
Fulfill requirements associated with offering all medications for Medication-Assisted Recovery approved by the Food and Drug Administration.
Form collaborative care partnerships with medical partners.
Deliver care according to a collaborative, coordinated model.
